...
首页> 外文期刊>Trials >An electronic family health history tool to identify and manage patients at increased risk for colorectal cancer: protocol for a randomized controlled trial
【24h】

An electronic family health history tool to identify and manage patients at increased risk for colorectal cancer: protocol for a randomized controlled trial

机译:电子家庭健康史工具,用于识别和管理罹患大肠癌风险增加的患者:一项随机对照试验的方案

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Colorectal cancer is the fourth most commonly diagnosed cancer in the United States. Approximately 3–10% of the population has an increased risk for colorectal cancer due to family history and warrants more frequent or intensive screening. Yet, ?50% of that high-risk population receives guideline-concordant care. Systematic collection of family health history and decision support may improve guideline-concordant screening for patients at increased risk of colorectal cancer. We seek to test the effectiveness of a web-based, systematic family health history collection tool and decision support platform (MeTree) to improve risk assessment and appropriate management of colorectal cancer risk among patients in the Department of Veterans Affairs primary care practices. In this ongoing randomized controlled trial, primary care providers at the Durham Veterans Affairs Health Care System and the Madison VA Medical Center are randomized to immediate intervention or wait-list control. Veterans are eligible if assigned to enrolled providers, have an upcoming primary care appointment, and have no conditions that would place them at increased risk for colorectal cancer (such as personal history, adenomatous polyps, or inflammatory bowel disease). Those with a recent lower endoscopy (e.g. colonoscopy, sigmoidoscopy) are excluded. Immediate intervention patients put their family health history information into a web-based platform, MeTree, which provides both patient- and provider-facing decision support reports. Wait-list control patients access MeTree 12?months post-consent. The primary outcome is the risk-concordant colorectal cancer screening referral rate obtained via chart review. Secondary outcomes include patient completion of risk management recommendations (e.g. colonoscopy) and referral for genetic consultation. We will also conduct an economic analysis and an assessment of providers’ experience with MeTree clinical decision support recommendations to inform future implementation efforts if the intervention is found to be effective. This trial will assess the feasibility and effectiveness of patient-collected family health history linked to decision support to promote risk-appropriate screening in a large healthcare system such as the Department of Veterans Affairs. ClinicalTrials.gov, NCT02247336 . Registered on 25 September 2014.
机译:大肠癌是美国第四大最常被诊断的癌症。大约3–10%的人口由于家族史而患结直肠癌的风险增加,因此需要更频繁或密集的筛查。然而,不到50%的高危人群接受了指南一致的护理。系统地收集家庭健康史和决策支持可以改善患有结直肠癌风险增加的患者的指南一致筛查。我们力图测试基于网络的系统的家庭健康史收集工具和决策支持平台(MeTree)的有效性,以改善退伍军人事务部初级保健实践中患者的风险评估和结直肠癌风险的适当管理。在这项正在进行的随机对照试验中,达勒姆退伍军人事务医疗系统和麦迪逊弗吉尼亚州医疗中心的初级保健提供者被随机分配到立即干预或等待名单控制中。如果将退伍军人分配给已注册的医疗服务提供者,并且即将接受初级保健任命,并且没有使大肠癌患病风险增加的条件(例如个人病史,腺瘤性息肉或炎症性肠病),则符合资格。近期内镜检查较低的患者(例如结肠镜检查,乙状结肠镜检查)被排除在外。即时干预患者将其家庭健康史信息放入基于Web的平台MeTree中,该平台提供面向患者和医务人员的决策支持报告。等候名单控制患者同意后12个月可以访问MeTree。主要结果是通过图表审查获得的风险一致性大肠癌筛查转诊率。次要结果包括患者完成风险管理建议(例如结肠镜检查)和转诊进行遗传咨询。如果发现干预有效,我们还将进行经济分析并评估提供者在MeTree临床决策支持建议中的经验,以告知未来的实施工作。该试验将评估患者收集的家庭健康史与决策支持相关的可行性和有效性,该决策支持可在大型医疗保健系统(例如退伍军人事务部)中促进风险适当的筛查。 ClinicalTrials.gov,NCT02247336。 2014年9月25日注册。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号